Jeffrey S. Hatfield - 22 May 2023 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Sung Lee, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
22 May 2023
Transactions value $
$0
Form type
4
Filing time
24 May 2023, 14:34:41
Previous filing
25 May 2022
Next filing
03 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +6.03K +61.63% $0.00 15.8K 22 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +12.1K $0.00 12.1K 22 May 2023 Common Stock 12.1K $25.74 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.